CN Bio appoints Dr Paul Brooks as Chief Executive Officer
Key strategic appointment as the Company enters next phase of commercial growth and global expansion of its products and services Former CEO, Dr David Hughes, appointed to Scientific Advisory BoardCambridge, UK, 19 December 2022:
New associate director joins CPFT research leadership team
Cambridgeshire and Peterborough NHS Foundation Trust (CPFT) welcomes Rasha DeMarco as the newly appointed Associate Director of Research and Development to lead on operational delivery and grow the Trust’s research portfolio.
Expansion continues for Biocair as firm reports substantial growth
The pharmaceutical, biotech and life sciences logistics expert, Biocair is marking another year of significant growth as it reports a 30% increase in sales volume year on year. Whilst also more than doubling its headcount to over 560 staff globally during the last two years.
Anthias Consulting partner with HEaTED to promote technical training courses
Anthias Consulting Ltd are pleased to announce a collaboration with HEaTED to provide their members with a 15% discount on Anthias scheduled courses in analytical science techniques.
Global Access Diagnostics joins consortium to co-develop on-farm rapid test for calf pneumonia, RaDiCal
Global Access Diagnostics (GADx), a social enterprise prioritising equitable access to diagnostics and driving local manufacturing, today announced the development of RaDiCal, a one-step molecular lateral flow test to enable rapid diagnosis of pneumonia, one of the most significant diseases affec
Assessing the impact of rarity on French HTA and pricing decisions
With changes to the pricing and access processes such as the new Accord Cadre and the soon-to-be implemented ATU reform likely to impact pricing and access of orphan products in France, Cécile Matthews
PhoreMost and ThinkCyte collaborate to advance AI based drug discovery
PhoreMost Ltd., the UK-based biopharmaceutical company dedicated to ‘Drugging the Undruggable®’ disease targets, and ThinkCyte K.K, a biotechnology company pioneering novel cell analysis and sorting instruments, today announced a strategic research partnership aimed at advancing modern
Sphere Fluidics appoints Richard Hammond as Chief Technical Officer
Key appointment forms part of ongoing plans to strengthen senior leadership team and support expansion of microfluidic product range for single cell analysis
Salus Wellness welcomes Emily Woollins to the team
Emily is an experienced Nutritional Therapist specializing in supporting clients with IBS (Irritable Bowel Syndrome) and other digestive disorders. She regularly works with clients suffering with pain, bloating, fatigue and suspected food intolerances.
Guardtech Group December Wrap-Up: a year of huge growth, joy and goodwill to all
As 2022 comes to a close, cleanroom construction specialists Guardtech joyously celebrate their busiest ever year.
How eligible patient numbers affect price of rare disease drugs in France
Having recently assessed the relationship between drug price and prevalence of non-oncology rare diseases, CRA’s Cécile Matthews, Bhavesh Patel, and Owen Male explore in greater depth the situation for these orphan
France’s ATU reform: Early access remains possible, but not all diseases are equal
When France’s ATU reform was implemented, some viewed it as restrictive.
Cambridge & Huntingdon based property firm Rapleys makes biggest acquisition in 72 years
London, UK - Rapleys announces it has welcomed London surveying firm Aston Rose into its business, the biggest single expansion in the partnership's 72 year history. The property consultancy has been on a strategic growth drive in recent months having onboarded planning practice CSJ in October and rebranding and repositioning the business in November.
The Native Antigen Company expands infectious disease portfolio to include Sudan Ebolavirus Boniface 1976 Glycoprotein
Antigen designed to support immunoassay and vaccine development applications
Leading UK Diagnostics provider Source LDPath expands AI capabilities with Ibex Medical Analytics
NHS Trusts Gain Access to Galen, Ibex's Multi-tissue AI Platform, Supporting Pathologists with Enhanced Diagnostic Accuracy and Efficiency
Metrion Biosciences and The KCNC1 Foundation collaborate on development of new ion channel modulators for ultra-rare genetic disorder
Research targeted at identifying novel inhibitors or activators of Kv3.1 mutation
Owlstone Medical launches Breath Biopsy VOC Atlas
Owlstone Medical (“Owlstone”), the global leader in Breath Biopsy® for applications in early disease detection and precision medicine, today announced the launch of the Breath Biopsy VOC Atlas, a catalogue of validated and quantitated volatile organic compounds (VOCs) found on breath.
Sync Neural Synchronised Impact fund: the ultimate investment vehicle to save the world?
London & Cambridge (UK) and Lucerne (Switzerland) - Sync Neural, the Swiss based holding company that addresses carbon neutrality, has signed a product partnership agreement with AlgoDynamix, the leader in behavioural-based price forecasting for financial markets. New investment products, including a Global Synchronised Impact fund, are expected in Q1 2023.
Shenandoah Biotechnology introduces expanded range of CTGrade recombinant proteins manufactured following cGMP practices
Shenandoah Biotechnology Inc., a FUJIFILM Irvine Scientific company and leading manufacturer of recombinant proteins, today announced it has expanded its CTGrade portfolio of cytokines and growth factors for cell and gene therapies manufactured following cGMP guidelines.
Mitigating risk: A conversation with Biocair's Sarah Pentney
Sarah Pentney, Biocair’s Global Quality and Compliance Manager, discusses how to stay up-to-date on the regulatory landscape and what is involved in mitigating risk when shipping Active Pharmaceutical Ingredients (APIs) and finished drug products.
Webcasting Plan B
“We pay you for when it goes wrong not for when it goes right” Roy Shepard executive producer explains why you need an experienced webcasting crew and always have a plan B.
Anne Glover and Hermann Hauser, reflecting on 25 years of Amadeus Capital Partners
As Amadeus celebrates 25 years since it was founded, Partner Amelia Armour sits down with Hermann Hauser and Anne Glover to reflect on the past three decades in our latest podcast episode.
Klebsiella pneumoniae vaccines - time to reprioritize
This month VacZine Analytics, a UK-based strategic research publisher exclusively focused on vaccines and infectious diseases, releases a brand-new global forecast of new Klebsiella pneumoniae vaccines.
International Day of Persons with Disabilities
International Day of Persons with Disabilities - an annual campaign aiming to join communities together to support people with disabilities and create a future for them where they experience equal opportunities and face no barriers in all aspects of their lives including employment.
South Africa expansion delivers growth opportunities for Biocair
Biocair has invested heavily in the expansion of its South Africa operation with the opening of two new offices.